CRONOS GROUP INC. Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted
CRONOS GROUP INC. (CRON) reported Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted of $32.09 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted · last filed 2026-08-06
- CRONOS GROUP INC. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2026-06-30 was $32.09M.
- CRONOS GROUP INC. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2026-03-31 was $13.75M, a 124.63% increase year-over-year.
- CRONOS GROUP INC. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2025-12-31 was -$1.82M, a 104.15% decline year-over-year.
- CRONOS GROUP INC. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2025-09-30 was $25.96M, a 210.91% increase year-over-year.
- CRONOS GROUP INC. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2025 was -$9.45M, a 123.00% decline from fiscal 2024.
- CRONOS GROUP INC. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2024 was $41.08M.
- CRONOS GROUP INC. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2023 was -$69.85M.
- CRONOS GROUP INC. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2022 was -$155.18M.
| Period end | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 3 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 3 month as first filed | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 6 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 6 month as first filed | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 9 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 12 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $32.09M 10-Q · filed 2026-08-06 | $45.84M 10-Q · filed 2026-08-06 | $44.02M derived: sum of 3 quarters · filed 2026-08-06 | $69.98M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $13.75M 10-Q · filed 2026-05-11 | $11.94M derived: sum of 2 quarters · filed 2026-05-11 | $37.89M derived: sum of 3 quarters · filed 2026-05-11 | -$1.82M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $24.14M derived: sum of 2 quarters · filed 2026-02-26 | -$15.57M derived: sum of 3 quarters · filed 2026-08-06 | -$9.45M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $25.96M 10-Q · filed 2025-11-06 | -$13.75M derived: sum of 2 quarters · filed 2026-08-06 | -$7.63M 10-Q · filed 2025-11-06 | $36.10M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$39.71M 10-Q · filed 2026-08-06 | -$33.59M 10-Q · filed 2026-08-06 | $10.14M derived: sum of 3 quarters · filed 2026-08-06 | $18.49M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $6.12M 10-Q · filed 2026-05-11 | $49.85M derived: sum of 2 quarters · filed 2026-05-11 | $58.20M derived: sum of 3 quarters · filed 2026-05-11 | $49.44M derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $43.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $52.08M derived: sum of 2 quarters · filed 2026-02-26 | $43.32M derived: sum of 3 quarters · filed 2026-02-26 | $41.08M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $8.35M 10-Q · filed 2025-11-06 | -$408.00K derived: sum of 2 quarters · filed 2025-11-06 | -$2.65M 10-Q · filed 2025-11-06 | -$47.56M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | -$8.76M 10-Q · filed 2025-08-07 | -$11.00M 10-Q · filed 2025-08-07 | -$55.91M derived: sum of 3 quarters · filed 2026-02-26 | -$57.37M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$2.24M 10-Q · filed 2025-05-08 | -$47.16M derived: sum of 2 quarters · filed 2026-02-26 | -$48.62M derived: sum of 3 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$44.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$46.38M derived: sum of 2 quarters · filed 2026-02-26 | -$69.85M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | -$1.46M 10-Q · filed 2024-11-12 | -$24.93M 10-Q · filed 2024-11-12 | |||||
| 2022-12-31 | -$65.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$102.32M derived: sum of 2 quarters · filed 2025-02-27 | -$155.18M 10-K · filed 2025-02-27 | -$168.73M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$36.99M 10-Q · filed 2022-11-07 | -$89.85M 10-Q · filed 2022-11-07 | |||||
| 2021-12-31 | -$133.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$55.80M derived: sum of 2 quarters · filed 2023-02-28 | -$234.32M derived: sum of 3 quarters · filed 2023-02-28 | -$395.61M 10-K · filed 2023-02-28 | |||
| 2021-09-30 | $77.83M 10-Q · filed 2022-11-07 | -$100.68M derived: sum of 2 quarters · filed 2022-11-07 | -$261.97M 10-Q · filed 2022-11-07 | -$371.69M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | -$178.51M 10-Q/A · filed 2022-02-18 | $57.62M 10-Q · filed 2021-08-06 | -$339.80M 10-Q/A · filed 2022-02-18 | -$103.68M 10-Q · filed 2021-08-06 | -$449.52M derived: sum of 3 quarters · filed 2023-02-28 | -$380.70M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | -$161.31M 10-Q · filed 2021-05-07 | -$271.01M derived: sum of 2 quarters · filed 2023-02-28 | -$202.19M derived: sum of 3 quarters · filed 2023-02-28 | -$309.85M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | -$109.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$40.88M derived: sum of 2 quarters · filed 2023-02-28 | -$148.54M derived: sum of 3 quarters · filed 2023-02-28 | -$72.49M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $68.82M 10-Q · filed 2022-02-18 | $68.83M 10-Q · filed 2020-11-05 | -$38.84M derived: sum of 2 quarters · filed 2022-02-18 | $37.21M 10-Q · filed 2022-02-18 | $873.88M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | -$107.66M 10-Q/A · filed 2022-02-18 | -$107.71M 10-Q · filed 2020-08-06 | -$31.62M 10-Q/A · filed 2022-02-18 | -$31.67M 10-Q · filed 2020-08-06 | $805.07M derived: sum of 3 quarters · filed 2022-03-01 | $1.40B derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $76.04M 10-Q · filed 2021-05-07 | $912.73M derived: sum of 2 quarters · filed 2022-03-01 | $1.51B derived: sum of 3 quarters · filed 2022-03-01 | $1.57B derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $836.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.43B derived: sum of 2 quarters · filed 2022-03-01 | $1.49B derived: sum of 3 quarters · filed 2022-03-01 | $1.14B 10-K · filed 2022-03-01 | $1.14B 10-K/A · filed 2020-03-30 | ||
| 2019-09-30 | $597.49M 10-Q · filed 2020-11-05 | $657.46M derived: sum of 2 quarters · filed 2020-11-05 | $305.76M 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | $59.97M 10-Q · filed 2020-08-06 | $149.33M 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | $89.37M 10-Q · filed 2020-05-08 | ||||||
| 2018-12-31 | -$20.74M 10-K · filed 2021-02-26 | -$21.64M 10-K/A · filed 2020-03-30 | |||||
| 2017-12-31 | -$1.48M 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |